<DOC>
	<DOCNO>NCT01171339</DOCNO>
	<brief_summary>Objective : To investigate whether complex intervention improve appropriateness prescription elderly multi-morbid patient multi-medication general practice . Study hypothesis : The primary objective study determine whether complex intervention improve appropriateness prescription compare usual care . The primary efficacy endpoint change Medication Appropriateness Index ( MAI ) score baseline ( T0 ) 6 month baseline ( T1 ) , i.e . difference MAI T1-T0 .</brief_summary>
	<brief_title>Prioritising Optimising Multi-medication Multimorbidity</brief_title>
	<detailed_description>Key element ( 1 4 ) complex intervention : 1 . Basic assessment medicine actually take ( brown bag review ) general practice base health care assistant ( HCA ) 2 . Checklist-based ( MediMoL - Medication-Monitoring-List ) pre-consultation interview problem relate medicine ( technical handling , potential adverse drug reaction ) patient 's therapeutic aim HCA provide structured information Medication-Monitoring-List ( MediMoL ) general practitioner ( GP ) enable patient discuss problem GP . 3 . GP use computerized decision support system ( pharmaceutical information system , AiD+ ) optimize medication ( reduce number inappropriate prescription , e.g . pharmaceutical interaction , renal dose adjustment , duplicate prescription ) 4. prioritizes medication physician-patient consultation take consideration patient 's preference .</detailed_description>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>least 60 year old sex least three chronic disease affect two organ system , require pharmaceutical treatment least five longterm prescription systemic effect health care provide GP ( least one contact recent quarter ) patient legally competent sign document ability understand participate trial free , fill questionnaire participate telephone interview write informed consent participate trial disease cause life expectancy le 12 month abuse alcohol illegal drug visible clinical sign symptom thereof cognitive impairment prevents trial participation ( MMSE &lt; 26 ) emotional stress prevents trial participation participation clinical trial within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>elderly</keyword>
	<keyword>multimorbidity</keyword>
	<keyword>polypharmacy</keyword>
	<keyword>multimedication</keyword>
	<keyword>medication appropriateness</keyword>
	<keyword>medication appropriateness index</keyword>
	<keyword>cluster-randomised control trial</keyword>
	<keyword>pragmatic trial</keyword>
</DOC>